Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients

Refractory bone and soft tissue sarcomas are challenging diseases to treat because of their robustness to chemotherapy. Although cancer vaccines have the potential to become an attractive treatment modality, their progress has been hampered by the presence of many subtypes of sarcomas and different...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Ryuji, Ishibashi, Yukinao, Hiraoka, Koji, Matsueda, Satoko, Kawano, Kouichirou, Kawahara, Akihiko, Kage, Masayoshi, Ohshima, Koichi, Yamanaka, Ryuya, Shichijo, Shigeki, Shirouzu, Kazuo, Itoh, Kyogo, Sasada, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656559/
https://www.ncbi.nlm.nih.gov/pubmed/23829867
http://dx.doi.org/10.1111/cas.12226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656559/
https://www.ncbi.nlm.nih.gov/pubmed/23829867
http://dx.doi.org/10.1111/cas.12226

Ejemplares similares